Please login to the form below

Not currently logged in
Email:
Password:

Publicis acquires India-based Watermelon

Publicis Groupe has agreed to acquire a majority stake in Watermelon Healthcare Communications, a leading healthcare advertising agency in Mumbai, India

Publicis Groupe has agreed to acquire a majority stake in Watermelon Healthcare Communications, a leading healthcare advertising agency in Mumbai, India.

Watermelon will become part of Publicis Healthcare Communications Group (PHCG) and will be renamed Publicis Life Brands (PLB) Watermelon. This transaction is subject to local closing conditions.

Watermelon is a full-service advertising agency that has built its business around traditional and new media since it was established in 2003.

Nearly 40 employees work to deliver strategic planning, digital and branding, creative, medical education, research, public relations, and healthcare professional and consumer communications. Its clients include AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Merck Specialties, MSD Pharmaceuticals, and Novartis.

The company's founders, Abhijit Shitut and Kiran Pai, are to be named joint managing directors at Publicis Life Brands Watermelon. Debasish Mukherjee, co-founder of the agency's digital arm Watermelon Digital Solutions, will spearhead the digital offerings of PLB Watermelon.

Shitut said: "We are excited to be a part of PHCG and believe this will help us change the landscape of healthcare communications in India.” Kiran Pai commented.

Ash Kuchel, president, PHCG Asia Pacific region (APAC) said: "PHCG is delighted to welcome Watermelon to our network. Watermelon is the right fit and has the expertise to further develop our healthcare communications credentials in new media and best-in-class practices in this important and rapidly emerging market. PHCG will continue to expand its global presence throughout the region in the near future."

22nd March 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...